|
Semenov A.P., Usufov A.G., Guspanov R.I., Kotov S.V.
Results of ejaculatory-protective laser enucleation of the prostate
|
№1 / 2025
|
|
Badakva G.V., Yusufov A.G., Bogdanov D.A., Kotov S.V.
Drug and behavioral therapy in the treatment of lower urinary tract symptoms that persist after surgical treatment of benign prostatic hyperplasia
|
№1 / 2025
|
|
Kamalov A.A., Sorokin N.I., Kadrev A.V., Gorbunov R.M., Mikhalchenko A.P., Koknaev S.G., Nesterova O.Yu., Strigunov A.A., Shaparov B. .M., Tsigura D.A., Osmanov O.A., Kritsky A.A., Sindeeva O.A., Abdurashitov A.S., Proshin P.I., Pyataev N.A., Sukhorukov G.B.
Efficiency and safety of using a urethral catheter with ultrasound-induced drug coating with methylprednisolone for programmed balloon dilation for the prevention of recurrence of bladder neck sclerosis in patients after endoscopic prostatic procedures
|
№6 / 2024
|
|
Pushkar D.Yu., Kolontarev K.B., Bernikov A.N.
Long-term use of Afalaza in patients with BPH: influence on the symptoms and risk of progression
|
№6 / 2024
|
|
Neymark A.I., Nozdrachev N.A., Kulchavenya E.V., Kholtobin D.P., Davydov A.V., Neymark A.B., Kovaleva Yu.S., Yakovlev A.V.
Use of the drug Prostatex plus in patients with chronic abacterial prostatitis and BPH
|
№2 / 2024
|
|
Kasyan G.R., Khodyreva L.A., Grigoryan B.L., Dyakov V.V.
Practical use of Adenoprosin® in combination therapy in men with lower urinary tract symptoms
|
№1 / 2024
|
|
Kamalov A.A., Sorokin N.I., Kadrev A.V., Shaparov B.M., Afanasevskaya E.V., Sindeeva O.A., Sukhorukov G.B., Kritsky A.A., Pyataev N.A., Abdurashitov A.S., Kulikov O.A., Proshin P.I.
The use of a urethral catheter with an ultrasound-induced biopolymer drug coating for the prevention of recurrent bladder neck sclerosis in patients after endoscopic treatment of benign prostate hyperplasia
|
№6 / 2023
|
|
Abdullaev Sh.P., Shatokhin M.N., Tuchkova S.N., Abdullaev Sh.P., Teodorovich O.V., Loran O.B., Sychev D.A.
Study of allelic variants of the CYP2D6 and CYP3A genes on the effectiveness and safety of tamsulosin therapy in patients with BPH: results of a pilot study
|
№6 / 2023
|
|
S.P. Abdullaev, M.N. Shatokhin, O.V. Teodorovich, D.A. Sychev
Molecular genetic predictors of the efficacy and safety of tamsulosin therapy
|
№6 / 2022
|
|
A.A. Zimichev, D.O. Gusev, D.Yu. Lukyanova
Evaluation of the efficacy of silodosin 8 mg in comorbid patients with LUTS/BPH
|
№6 / 2022
|
|
D.Yu. Pushkar, O.B. Loran, A.N. Bernikov
The influence of alfuzosin monotherapy on the sexual function of patients with benign prostatic hyperplasia in real clinical practice (results of a Russian multicenter study)
|
№6 / 2022
|
|
A.G. Martov, A.S. Dukhanin, A.N. Bernikov
Current issues in alpha1-adrenergic blocker therapy: integration of pharmacological approach and clinical experience
|
№3 / 2022
|
Русский
